InsiderTrades

Form 4 for TECH Bio-Techne

Accepted 2025-02-07 00:00:00 ET · period of report 2025-02-03 · accession 0001062993-25-001897 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-07 2025-02-03 TECH Herr Amy E. Dir A - Grant $0.00 +1,040 1,040 New $0
D 2025-02-07 2025-02-03 TECH Herr Amy E. Dir A - Grant $0.00 +2,415 2,415 New $0
DMI 2025-02-07 2025-02-03 TECH Herr Amy E. Dir A - Grant $0.00 +459 344 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-03 A A 1,040 $0.00 1,040 D — —
2 Derivative Stock Option (Right to Buy) 2025-02-03 A A 2,415 $0.00 2,415 D By significant other $72.05 · — to 2035-02-03 2,415 Common Stock (F1) The option vests on the earlier of the one-year anniversary of the grant date or the date of Bio-Techne's annual meeting of shareholders.
3 Derivative Restricted Stock Units 2025-02-03 A A 115 $0.00 115 I — · — to — 115 Common Stock (F8) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F11) 38 restricted stock units vest on each of 2/3/2026 and 2/3/2027, and 39 restricted stock units vest on 2/3/2028.
4 Derivative Stock Option (Right to Buy) 2025-02-03 A A 344 $0.00 344 I By significant other $72.05 · — to 2025-02-03 344 Common Stock (F7) 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.